Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infectious Respiratory Disease Diagnostics Market 

5.1. COVID-19 Landscape: Infectious Respiratory Disease Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infectious Respiratory Disease Diagnostics Market, By Product Type

8.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Product Type, 2023-2032

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Infectious Respiratory Disease Diagnostics Market, By Sample Type

9.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Sample Type, 2023-2032

9.1.1. Saliva

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Nasopharyngeal Swabs (NPS)

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Anterior Nasal Region

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Blood

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Infectious Respiratory Disease Diagnostics Market, By Application 

10.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Application, 2023-2032

10.1.1. COVID-19

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Influenza

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. RSV (Respiratory Syncytial Virus)

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Tuberculosis

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Streptococcus Testing

10.1.5.1. Market Revenue and Forecast (2020-2032)

10.1.6. Other

10.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Infectious Respiratory Disease Diagnostics Market, By Technology 

11.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Technology, 2023-2032

11.1.1. Immunoassay

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Molecular Diagnostics

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Microbiology

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Other

11.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Infectious Respiratory Disease Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.1.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.1.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Forecast, by Technology (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.2.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.2.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Technology (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.3.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.3.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Technology (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.4.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.4.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Technology (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Technology (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Technology (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product Type (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Technology (2020-2032)

Chapter 13. Company Profiles

13.1. F. Hoffmann-La Roche Ltd.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Abbott Laboratories

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Becton, Dickinson and Company

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Thermo Fisher Scientific Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Siemens Healthineers AG

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. QIAGEN N.V.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Bio-Rad Laboratories, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Cepheid (Danaher Corporation)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Hologic, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Luminex Corporation

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms